Palliative fractionated radiotherapy for bone metastases clinical and biological assessment of single versus multiple fractions.

Background: Radiotherapy is effective in controlling pain from bone metastases which is a direct result of bone resorption. The urine resorption marker DPD proved important in assessing effectiveness of palliative radiotherapy to bone metastases. There is still controversy about the optimum adopted fractionation regimen.